No recorded roll-call vote on this bill yet
This bill clarifies that the in-office ancillary services exception to the physician self-referral prohibition applies to drugs and their administration supplies under Medicare, without requiring them to be furnished in a specific location. Sec. 2, Clarifying the exception for drugs: The bill amends the Social Security Act to state that, for drugs and supplies furnished on or after May 11, 2023, the requirement that they be provided in a specific setting (as per subparagraph (A)(ii)) does not apply to qualify for the in-office ancillary services exception. It also directs the Secretary of Health and Human Services to remove certain FAQs from the Centers for Medicare & Medicaid Services website that prohibited such arrangements, and those FAQs are considered void.
Summary of the bill text as introduced in Senate (Dec 11, 2023), generated by SecBot from the official bill text; the Library of Congress summary is not yet published.
No amendments offered
No cost estimate or committee report yet
Official record from Congress.gov, the House Clerk and the Senate; lobbying from Lobbying Disclosure Act filings. Updated Oct 27, 2026.